Pfizer's not the only drug company raising prices

CNN Politics 5 days ago

Pfizer caved to pressure from President Donald Trump to temporarily roll back its drug price increases. But the pharmaceutical company isn't the only one hiking list prices in recent months.

Until Pfizer's announcement Tuesday, few drug manufacturers appeared to pay heed to the president's exhorting them to reduce costs.

In fact, manufacturers increased the cost of 104 drugs in June and the first two days of July alone, only weeks after the administration unveiled a blueprint aimed at addressing drug prices, according to a recent Wells Fargo Securities report. For instance, Teva Pharmaceutical (TEVA) raised the price of several of its brand-name medicines by more than 9% at the end of June, while Novo Nordisk (NONOF) recently raised the price of insulin drug Tresiba by 5%.

Novo Nordisk said Wednesday it would not follow Pfizer's lead.

"We don't intend to reverse our list price increases, which are in line with our promise to keep annual list price increases below 10%," said Ken Inchausti, a spokesman for Novo Nordisk.

Neither Teva nor PhRMA, the industry's trade group, responded to requests for comment.

Related: Pfizer puts price hikes on hold after Trump complains

Pfizer's concession, however, is likely to have a "chilling effect" on other drug firms looking to raise their prices, said David Maris, senior analyst at Wells Fargo. He noted that Pfizer had a public relations nightmare on their hands, especially after Trump tweeted earlier this week that the pharmaceutical powerhouse -- and others -- should be "ashamed" of themselves.

"The intensity of the drug pricing debate has increased among the country's constituents, and legislators are listening," he wrote in a note Wednesday.

Pfizer (PFE) isn't making a huge sacrifice. It agreed to roll back the price increases it implemented on July 1, but only until the end of the year at the latest. This won't have a huge impact on the company's bottom line, especially since it raised prices on many medications earlier this year.

Here's an example: Pfizer increased its list price on a 90-pill bottle of cholesterol drug Lipitor this month to $983. Now, it will return to $898, but that's still up from $820 last year.

Related: Trump lays out his vision for lower drug prices

Drug manufacturers have already been curbing their price hikes in recent years, according to Adam Fein, president of Pembroke Consulting, which focuses on the pharmaceutical industry. Also, many companies are raising prices only once a year instead of twice. This is largely because a growing number of consumers have to pay list prices because of changes to their employer-sponsored health insurance.

Source link
Read also:
The New York Times Politics 5 days ago
The company said it would roll back increases that took effect July 1 to give the president a chance to work on his “blueprint” to lower prices and...
NPR News Politics 5 days ago
The pharmaceutical company Pfizer says it will delay price increases that went into effect on July 1. The move follows pressure from President Trump...
Miami Herald 5 days ago
A twice-convicted killer scheduled to be executed Wednesday night in Nevada by an untried three-drug lethal injection is steadfast in his desire to...
CBS News Politics 5 days ago
WASHINGTON -- Pharmaceutical company Pfizer said in a statement Tuesday that CEO Ian Read had agreed to "defer the company's price increases that...
ABC News Politics 5 days ago
Interested in Donald Trump? Add Donald Trump as an interest to stay up to date on the latest Donald Trump news, video, and analysis from ABC News...
TIME Politics 6 days ago
WASHINGTON — President Donald Trump says pharmaceutical company Pfizer is “rolling back price hikes, so American patients don’t pay more.” Trump is...
Axios 6 days ago
Pharmaceutical companies have raised the prices of 43 generic drugs by at least 10% so far in the first half of 2018, according to an analysis from...
NDTV News Politics 6 days ago
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers (Reuters)New York/Washington: US President Donald Trump on Monday...
One click to connect
Select a social network to associate your account